Product Images Simvastatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Simvastatin NDC 71610-610 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bottle Label 40 mg - 71610 0609 45

Bottle Label 40 mg - 71610 0609 45

Bottle Label 40 mg - 71610 0610 45

Bottle Label 40 mg - 71610 0610 45

Bottle Label 80 mg - 71610 0611 45

Bottle Label 80 mg - 71610 0611 45

Not available. The given text seems to be an incorrect output.*

Aphena Pharma Solutions - TN - Aphena

Aphena Pharma Solutions - TN - Aphena

Footnote for Table 3 - Footnote for Table 3

Footnote for Table 3 - Footnote for Table 3

This text provides information on the results of a chemical assay, and the potential inhibitors that could affect CYP3A4. It also clarifies that "Simvastatin acid" refers to the p-hydroxyacid of simvastatin. However, there is a lack of information on the effect of grapefruit juice on simvastatin pharmacokinetics. The text provides details about the administration of grapefruit juice in double-strength and single-strength doses, along with simvastatin.*

Figure 9 - simvastatin 10

Figure 9 - simvastatin 10

table2 - simvastatin 2

table2 - simvastatin 2

Structure - simvastatin 3

Structure - simvastatin 3

table 3 - simvastatin 4

table 3 - simvastatin 4

Not available.*

table 4 - simvastatin 5

table 4 - simvastatin 5

Figure 5 - simvastatin 6

Figure 5 - simvastatin 6

Figure 6 - simvastatin 7

Figure 6 - simvastatin 7

Figure 7 - simvastatin 8

Figure 7 - simvastatin 8

Figure 8 - simvastatin 9

Figure 8 - simvastatin 9

table 1 - table1

table 1 - table1

This is a list of drug interactions associated with increased risk of myopathy/rhabdomyolysis. The list includes prescribing recommendations for interacting agents such as strong CYP3A4 inhibitors, HIV protease inhibitors, and other medications. Simvastatin, a cholesterol-lowering medication, should not be taken with certain medications such as verapamil, diltiazem, and amiodarone, unless under specific prescribing recommendations. Additionally, niacin should not be taken with simvastatin while for patients with HOFH, Lomitapide should not be used. There is an instruction to avoid grapefruit juice as well.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.